Erasca Inc - ERAS Company Long-Term Liabilities

Erasca Inc - graphic logo of issuer ERAS

The Erasca, Inc. (ERAS) market price chart illustrates the price action of an asset with a debt load currently at 0.04. Erasca, Inc. (ERAS) is advancing oncology medicine through alliances with research centers and the acquisition of small biotech studios. Business growth is driven by targeted tumor therapies (the RAS/MAPK pathway) and contracts with industry behemoths. The company is currently developing high-social-impact drugs that are undergoing clinical trials.

ERAS (erasca.com) Company Long-Term Debt history from 07/04/2022 to 10/28/2026

Erasca Corp - analytical breakdowns and key metrics (ERAS)

- price and consensus price forecast:
Share Price erasca.com|ERAS - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Erasca|ERAS - Enterprise Value
- book capitalization data:
Net Asset Value per Share Erasca|ERAS - Company Book Value|Market Value to Book Value erasca.com|ERAS - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Erasca, Inc.|ERAS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Erasca Oncology|ERAS - Company Total Debt|Debts to Book Capitalization Erasca|ERAS - Company Long-Term Debt|Company Short-Term Loans and Borrowings Erasca
Summary company analytics:erasca.com (ERAS)
Original product of Erasca, Inc.

Investors must find a balance between capital expenditures and insolvency risks. The patent platform of Erasca, Inc. (ERAS) for developing cancer inhibitors protects the business from competitors but requires large-scale funding for FDA trials. The long-term debt dynamics of Erasca, Inc. (ERAS) on this chart reflect the volume of multi-year credit obligations, filtering out market noise. A decrease in this metric confirms the company's financial autonomy and resilience to cash flow gaps.

Analysis of competing companies

Company Long-Term Indebtedness beigene.com ONC|HALO: Company Long-Term Debts|RVMD - Company Long-Term Liabilities|Company Long-Term Debts AAPG|CGON (CG Oncology Therapeutics) - Long-Term Debt|URGN - Company Long-Term Debt|Company Long-Term Loans and Borrowings bicara.com (BCAX)|Personalis (PSNL) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Delcath Systems Inc (DCTH)|YmAbs - Company Long-Term Debts|AURA - Company Long-Term Liabilities|Candel - Company Long-Term Liabilities|ARAY: Company Long-Term Debts|Company Long-Term Debt sellaslifesciences.com SLS|Actuate Therapeutics Inc. (ACTU) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CTOR (Citius Oncology, Inc)|Long-Term Debt TuHURA|Protara Therapeutics - Company Long-Term Debts|Long-Term Debt FATE (fatetherapeutics.com)|Company Long-Term Debt Aadi Bioscience|Company Long-Term Loans and Borrowings TScan Therapeutics Inc TCRX|Champions Oncology Corp - Company Long-Term Debts|XBIT: Company Long-Term Debts|cel-sci.com - Company Long-Term Debt|ostherapies.com (OSTX) - Long-Term Debt Volume|Company Long-Term Debts RADX|Company Long-Term Liabilities Artiva|Company Long-Term Debts ANL|Company Long-Term Debts Veru Corporation VERU|Company Long-Term Liabilities Tempest Therapeutics|Company Long-Term Loans and Borrowings Xilio Therapeutics Inc XLO|Company Long-Term Debts RENB (Enochian BioSciences)|MURA: Long-Term Debt Volume|Company Long-Term Debt kairospharma.com|OnKure Therapeutics (OKUR) - Company Long-Term Indebtedness|Company Long-Term Debts GDTC|Company Long-Term Liabilities Curis Corp (CRIS)|APLM (Apollomics, Inc.) - Company Long-Term Liabilities|Long-Term Debt Volume Tharimmune Inc (THAR)|ADVB: Company Long-Term Debts|Genprex Inc - Long-Term Debt|Company Long-Term Debt Calidi Bio (CLDI)|SBFM - Company Long-Term Loans and Borrowings|XBIO: Company Long-Term Debts|SLRX (Salarius Pharmaceuticals Inc) - Company Long-Term Debts|PPBT: Company Long-Term Debt|Long-Term Debt Volume AON|Company Long-Term Debts BGNE (BeiGene, Ltd.)|Company Long-Term Liabilities checkpointtx.com (CKPT)|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|iCAD Inc. - Company Long-Term Debts|Ikena (IKNA) - Company Long-Term Debt|NTBL - Company Long-Term Indebtedness|VIRX (viracta.com) - Company Long-Term Debts|morphosys.com (MOR) - Company Long-Term Liabilities|Company Long-Term Debts NAYA (NAYA Biosciences Inc.)|Long-Term Debt AAPGV